Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
Each company listed discloses FDMT in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named FDMT in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Kristian Humer | $66,000 | $50,000 | $0 | $3,874,656 | $0 | $0 | $247 | $3,990,903 |
| Chief Financial Officer | ||||||||
| David Kirn | 667,252 | 0 | 0 | 822,750 | 560,597 | 0 | 744 | 2,051,343 |
| President and Chief Executive Officer | ||||||||
| Fariborz Kamal | 551,743 | 0 | 0 | 548,705 | 339,513 | 0 | 1,612 | 1,441,573 |
| Former Chief Operating Officer & President | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Kristian Humer | $3,990,903 | — | — | — |
| David Kirn | 2,051,343 | 1,009,004 | — | +1,042,339 |
| Fariborz Kamal | 1,441,573 | 734,607 | — | +706,966 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| David Kirn | Director | 2026-06-01 | D | 1,922 | $10 | $19,258 | Common, open-market sale | Form 4 ↗ |
| Glenn Sblendorio | Director | 2026-06-17 | A | 50,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jacob Chacko | Director | 2026-06-17 | A | 50,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Shawn Tomasello | Director | 2026-06-17 | A | 50,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| John F. Milligan | Director | 2026-06-17 | A | 75,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Nancy Miller-Rich | Director | 2026-06-17 | A | 50,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles Theuer | Director | 2026-06-17 | A | 50,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Susannah Gray | Director | 2026-06-17 | A | 50,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Kirn | Director | 2026-06-22 | D | 114,746 | 10 | 1,200,851 | Common, open-market sale | Form 4 ↗ |
| Scott Bizily | Chief Legal Officer | 2026-06-23 | A | 9,810 | 4 | 40,613 | Common | Form 4 ↗ |
| Scott Bizily | Chief Legal Officer | 2026-06-23 | D | 9,810 | 12 | 117,720 | Common | Form 4 ↗ |
| Scott Bizily | Chief Legal Officer | 2026-06-23 | D | 9,810 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Scott Bizily | Chief Legal Officer | 2026-06-30 | A | 814 | 4 | 3,370 | Common | Form 4 ↗ |
| Scott Bizily | Chief Legal Officer | 2026-06-30 | D | 6,566 | 14 | 91,924 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-06-30 | — | 814 | — | — | 1 insider, 1 accrual row | ||
| Scott Bizily | Chief Legal Officer | 2026-06-30 | D | 5,752 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Scott Bizily | Chief Legal Officer | 2026-06-30 | A | 5,752 | 6 | 37,330 | Common | Form 4 ↗ |
| David Kirn | Director | 2026-07-09 | D | 15,283 | 12 | 183,560 | Common, open-market sale | Form 4 ↗ |
| David Kirn | Director | 2026-07-09 | D | 42,608 | 13 | 548,177 | Common, open-market sale | Form 4 ↗ |
| David Kirn | Director | 2026-07-09 | D | 442 | 13 | 5,673 | Common, open-market sale | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| David Kirn | Director | 2026-06-01 | D | 1,922 | $10 | $19,258 | Common, open-market sale | Form 4 ↗ |
| Glenn Sblendorio | Director | 2026-06-17 | A | 50,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jacob Chacko | Director | 2026-06-17 | A | 50,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Shawn Tomasello | Director | 2026-06-17 | A | 50,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| John F. Milligan | Director | 2026-06-17 | A | 75,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Nancy Miller-Rich | Director | 2026-06-17 | A | 50,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles Theuer | Director | 2026-06-17 | A | 50,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Susannah Gray | Director | 2026-06-17 | A | 50,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Kirn | Director | 2026-06-22 | D | 114,746 | 10 | 1,200,851 | Common, open-market sale | Form 4 ↗ |
| Scott Bizily | Chief Legal Officer | 2026-06-23 | A | 9,810 | 4 | 40,613 | Common | Form 4 ↗ |
| Scott Bizily | Chief Legal Officer | 2026-06-23 | D | 9,810 | 12 | 117,720 | Common | Form 4 ↗ |
| Scott Bizily | Chief Legal Officer | 2026-06-23 | D | 9,810 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Scott Bizily | Chief Legal Officer | 2026-06-30 | A | 814 | 4 | 3,370 | Common | Form 4 ↗ |
| Scott Bizily | Chief Legal Officer | 2026-06-30 | D | 6,566 | 14 | 91,924 | Common | Form 4 ↗ |
| Scott Bizily | Chief Legal Officer | 2026-06-30 | D | 814 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Scott Bizily | Chief Legal Officer | 2026-06-30 | D | 5,752 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Scott Bizily | Chief Legal Officer | 2026-06-30 | A | 5,752 | 6 | 37,330 | Common | Form 4 ↗ |
| David Kirn | Director | 2026-07-09 | D | 15,283 | 12 | 183,560 | Common, open-market sale | Form 4 ↗ |
| David Kirn | Director | 2026-07-09 | D | 42,608 | 13 | 548,177 | Common, open-market sale | Form 4 ↗ |
| David Kirn | Director | 2026-07-09 | D | 442 | 13 | 5,673 | Common, open-market sale | Form 4 ↗ |
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| David Kirn | Option | — | — | — | — | — | $822,750 |
| Fariborz Kamal | Option | — | — | — | — | — | 548,705 |
| Kristian Humer | Option | — | — | — | — | — | 3,874,656 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| David Kirn | $0 | $0 | $822,750 | 0.0% |
| Fariborz Kamal | 0 | 0 | 548,705 | 0.0% |
| Kristian Humer | 0 | 0 | 3,874,656 | 0.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| David Kirn | Option | 6,250 | 15.78 | — |
| Fariborz Kamal | Option | 2,917 | 15.78 | — |
| Fariborz Kamal | Option | 11,250 | 8.04 | — |
| Fariborz Kamal | Option | 2,813 | 8.06 | — |
| Fariborz Kamal | Option | 130,000 | 14.42 | — |
| Kristian Humer | Option | 480,000 | 10.51 | — |
| David Kirn | Option | 217,344 | 4.14 | — |
| Fariborz Kamal | Option | 144,950 | 4.14 | — |
| David Kirn | Option | 64,750 | 20.24 | — |
| David Kirn | Option | 295,000 | 14.42 | — |
| Fariborz Kamal | Option | 21,875 | 20.24 | — |
We seek to ensure that the total compensation paid to our executive officers is reasonable and competitive. Compensation of our executives is structured around the achievement of individual performance and near-term corporate targets as well as long-term business objectives.
| CEO STI target (% of salary) | 60% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Radford (part of the Rewards Solutions practice at Aon plc) |
| Clawback policy | True |
| Anti-hedging | true |
| Anti-pledging | false |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-06-17 | 36,065,437 | 940,414 | 67,379 | 97.46% | Passed |
| 2025 | 2025-06-17 | 31,841,967 | 394,002 | 35,446 | 98.78% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-06-17 | 97.46%a |
| 2025 | 2025-06-17 | 98.78%b |
a. Approved under the standard stated in the filing — “Abstentions and broker non-votes will also have no effect on Proposal 3.”.
b. Approved under the standard stated in the filing — “Abstentions and broker non-votes will also have no effect on Proposal 3 and Proposal 4.”.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Ratio (CEO : median employee) | — |
|---|---|
| CEO total compensation | — |
| Median employee compensation | — |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| John F. Milligan, Ph.DNot independent · Board Chair | $150,000 | $0 | $105,000 | — | $0 | $255,000 |
| Charles Theuer, M.D., Ph.DIndependent · Audit · Nominating/Governance · Science and Technology (Chair) | 65,000 | 0 | 70,000 | — | 0 | 135,000 |
| Susannah Gray, MBAIndependent · Audit · Compensation (Chair) | 65,000 | 0 | 70,000 | — | 0 | 135,000 |
| Jacob Chacko, M.D., MBAIndependent · Audit (Chair) · Nominating/Governance | 65,000 | 0 | 70,000 | — | 0 | 135,000 |
| Shawn Cline Tomasello, MBAIndependent · Compensation · Nominating/Governance (Chair) · Science and Technology | 62,500 | 0 | 70,000 | — | 0 | 132,500 |
| Nancy Miller-RichIndependent · Compensation · Science and Technology | 52,500 | 0 | 70,000 | — | 0 | 122,500 |
| David Kirn, M.DEmployee director | 0 | 0 | 0 | — | 0 | 0 |
| Glenn SblendorioIndependent · Compensation · Science and Technology · Newly elected | 0 | 0 | 0 | — | 0 | 0 |
| Annual cash retainer | $40,000 |
|---|---|
| Annual equity retainer | $70,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 10,000 / 20,000 / 5,000 |
| Stock ownership guideline | — |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $460,000 |
| Equity awards (grant-date value) | $0 |
| All other compensation | $0 |
| Total cost of the board | $460,000 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | 4D Molecular Therapeutics | 2025 | David Kirn | $667,252 | $0 | $822,750 | $560,597 | $2,051,343 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Kristian Humer | DEF 14A | 2026-04-28 | 0001140361-26-017427 | Section “2025 Summary Compensation Table”. As printed: 3,990,903. Filing ↗machine: r4 · c21 · span 364041–364050 |
| 2 | Section 01, David Kirn | DEF 14A | 2026-04-28 | 0001140361-26-017427 | Section “2025 Summary Compensation Table”. As printed: 2,051,343. Filing ↗machine: r2 · c21 · span 356185–356194 |
| 3 | Section 01, Fariborz Kamal | DEF 14A | 2026-04-28 | 0001140361-26-017427 | Section “2025 Summary Compensation Table”. As printed: 1,441,573. Filing ↗machine: r5 · c21 · span 368780–368789 |
| 4 | Section 03, David Kirn Option | DEF 14A | 2026-04-28 | 0001140361-26-017427 | Section “TABLE OF CONTENTS EXECUTIVE COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t85 · r2 · c12 · span 354422–354429 |
| 5 | Section 03, Fariborz Kamal Option | DEF 14A | 2026-04-28 | 0001140361-26-017427 | Section “TABLE OF CONTENTS EXECUTIVE COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t85 · r5 · c12 · span 367012–367019 |
| 6 | Section 03, Kristian Humer Option | DEF 14A | 2026-04-28 | 0001140361-26-017427 | Section “TABLE OF CONTENTS EXECUTIVE COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t85 · r4 · c12 · span 362526–362535 |
| 7 | Section 07, pay ratio | 10-K | 2026-03-18 | 0001193125-26-114075 | Section “CEO Pay Ratio”. As printed: —. Filing ↗ |
| 8 | Section 08, John F. Milligan, Ph.D | DEF 14A | 2026-04-28 | 0001140361-26-017427 | Section “Director Compensation”. As printed: 255,000. Filing ↗machine: r2 · c12 · span 300389–300396 |
| 9 | Section 08, Charles Theuer, M.D., Ph.D | DEF 14A | 2026-04-28 | 0001140361-26-017427 | Section “Director Compensation”. As printed: 135,000. Filing ↗machine: t76 · r3 · c12 · span 302683–302690 |
| 10 | Section 08, Susannah Gray, MBA | DEF 14A | 2026-04-28 | 0001140361-26-017427 | Section “Director Compensation”. As printed: 135,000. Filing ↗machine: t76 · r5 · c12 · span 307609–307616 |
| 11 | Section 08, Jacob Chacko, M.D., MBA | DEF 14A | 2026-04-28 | 0001140361-26-017427 | Section “Director Compensation”. As printed: 135,000. Filing ↗machine: t76 · r4 · c12 · span 305324–305331 |
| 12 | Section 08, Shawn Cline Tomasello, MBA | DEF 14A | 2026-04-28 | 0001140361-26-017427 | Section “Director Compensation”. As printed: 132,500. Filing ↗machine: r7 · c12 · span 312411–312418 |
| 13 | Section 08, Nancy Miller-Rich | DEF 14A | 2026-04-28 | 0001140361-26-017427 | Section “Director Compensation”. As printed: 122,500. Filing ↗machine: t76 · r6 · c12 · span 310244–310251 |
| 14 | Section 08, David Kirn, M.D | DEF 14A | 2026-04-28 | 0001140361-26-017427 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 15 | Section 08, Glenn Sblendorio | DEF 14A | 2026-04-28 | 0001140361-26-017427 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 16 | Section 02, David Kirn 2026-06-01 | Form 4 | 2026-06-02 | 0001193125-26-253740 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 17 | Section 02, Glenn Sblendorio 2026-06-17 | Form 4 | 2026-06-18 | 0001193125-26-276144 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 18 | Section 02, Jacob Chacko 2026-06-17 | Form 4 | 2026-06-18 | 0001193125-26-276138 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 19 | Section 02, Shawn Tomasello 2026-06-17 | Form 4 | 2026-06-18 | 0001193125-26-276168 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 20 | Section 02, John F. Milligan 2026-06-17 | Form 4 | 2026-06-18 | 0001193125-26-276149 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 21 | Section 02, Nancy Miller-Rich 2026-06-17 | Form 4 | 2026-06-18 | 0001193125-26-276163 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 22 | Section 02, Charles Theuer 2026-06-17 | Form 4 | 2026-06-18 | 0001193125-26-276166 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 23 | Section 02, Susannah Gray 2026-06-17 | Form 4 | 2026-06-18 | 0001193125-26-276160 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 24 | Section 02, David Kirn 2026-06-22 | Form 4 | 2026-06-23 | 0001834021-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 25 | Section 02, Scott Bizily 2026-06-23 | Form 4 | 2026-06-25 | 0001920738-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 26 | Section 02, Scott Bizily 2026-06-23 | Form 4 | 2026-06-25 | 0001920738-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 27 | Section 02, Scott Bizily 2026-06-23 | Form 4 | 2026-06-25 | 0001920738-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 28 | Section 02, Scott Bizily 2026-06-30 | Form 4 | 2026-07-02 | 0001920738-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 29 | Section 02, Scott Bizily 2026-06-30 | Form 4 | 2026-07-02 | 0001920738-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 30 | Section 02, Scott Bizily 2026-06-30 | Form 4 | 2026-07-02 | 0001920738-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 31 | Section 02, Scott Bizily 2026-06-30 | Form 4 | 2026-07-02 | 0001920738-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 32 | Section 02, Scott Bizily 2026-06-30 | Form 4 | 2026-07-02 | 0001920738-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 33 | Section 02, David Kirn 2026-07-09 | Form 4 | 2026-07-14 | 0001834021-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 34 | Section 02, David Kirn 2026-07-09 | Form 4 | 2026-07-14 | 0001834021-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 35 | Section 02, David Kirn 2026-07-09 | Form 4 | 2026-07-14 | 0001834021-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 36 | Section 06, 2026 vote | Form 8-K | 2026-06-22 | 0001193125-26-277563 | Item 5.07 · say-on-pay result. As reported: 97.46% (votes for as printed: 36,065,437). Filing ↗ |
| 37 | Section 06, 2025 vote | Form 8-K | 2025-06-20 | 0000950170-25-088482 | Item 5.07 · say-on-pay result. As reported: 98.78% (votes for as printed: 31,841,967). Filing ↗ |
| 38 | Section 01 trend, Δ column (computed) | Computed | — | computed | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 39 | Section 03b vehicle mix (computed) | Computed | — | computed | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 40 | Section 09b board cost (computed) | Computed | — | computed | Cash 460,000 + equity 0 + all other 0 = 460,000, summed across the director compensation table rows.machine: formula: Σ = 460,000 |
| 41 | 4D Molecular Therapeutics (subject), Section 10b CEO total | DEF 14A | 2026-04-28 | 0001140361-26-017427 | CEO total compensation as printed in 4D Molecular Therapeutics's own proxy. As printed: 2,051,343. Filing ↗machine: r2 · c21 · span 356185–356194 |